Categories
Tags
Authors: Darwin E, Hirt PA, Fertig R, Doliner B, Delcanto G PMID: 29769777 PMCID: PMC5939003 DOI: 10.4103/ijt.ijt_99_17 Abstract Alopecia areata (AA) is a complex autoimmune condition that causes nonscarring hair loss. It typically presents with sharply demarcated round patches of hair loss and may present at any age. In this article, we review the epidemiology, [...]
Categories: I-RECOVER Post-Vaccine
Tags: Alopecia
Authors: Swank Z, Senussi Y, Alter G, Walt DR PMID: 36052466 PMCID: PMC10169416 DOI: 10.1093/cid/ciac722 Abstract The diagnosis of postacute sequelae of coronavirus disease 2019 (PASC) poses an ongoing medical challenge. To identify biomarkers associated with PASC we analyzed plasma samples collected from PASC and coronavirus disease 2019 patients to quantify viral antigens and inflammatory [...]
Categories: I-RECOVER Post-Vaccine
Tags: SARS-CoV-2, sequelae
Authors: Atoui A, Jarrah K, Al Mahmassani L, Bou-Fakhredin R, Taher AT PMID: 35083524 PMCID: PMC8791702 doi: 10.1007/s00277-021-04743-1 Abstract Severe side effects of adenoviral-vectored-DNA COVID-19 vaccines such as thrombosis have been reported. Herein, we report a case of sudden massive deep vein thrombosis (DVT) in a young man with inferior vena cava anomaly 20 hours [...]
Categories: I-RECOVER Post-Vaccine
Authors: Zilberman-Itskovich S, Catalogna M, Sasson E, Hadanny A, Lang E, Finci S et al. PMID: 36261911 DOI: 10.1097/01.NAJ.0000897152.36663.7a Abstract According to this study: Hyperbaric oxygen therapy can improve cognitive function, psychiatric symptoms, pain, and fatigue in patients who have post-COVID-19 condition.The beneficial effect of the therapy can be attributed to increased brain perfusion and [...]
Categories: I-RECOVER Post-Vaccine
Authors: Chen JJ, Zeng BY, Lui CC, Chen TY, Chen YW, Tseng PT PMID: 35583323 PMCID: PMC9129164 DOI: 10.1093/qjmed/hcac124 Abstract The COVID-19 vaccine had been recognized as one of the most important weapons to fight COVID-19. However, the COVID-19 vaccine-associated tinnitus, although not a severe adverse event, had attracted the clinicians’ attention gradually.1 Although it [...]
Categories: I-RECOVER Post-Vaccine
Authors: Cadegiani FA PMID: 35971401 PMCID: PMC9372380 DOI: 10.7759/cureus.27883 Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine-induced myocarditis is a rare but well-documented complication in young males. The increased incidence of sudden death among athletes following vaccination has been reported and requires further investigation. Whether the risk of myocarditis, [...]
Categories: I-RECOVER Post-Vaccine
Authors: Freitag K, Sterczyk N, Wendlinger S, Schulz J, Ralser M, Fleck L et al. PMID: 35780157 PMCID: PMC9250727 DOI: 10.1186/s12974-022-02534-7 Abstract Background: Deposition of amyloid beta (Aβ) and hyperphosphorylated tau along with glial cell-mediated neuroinflammation are prominent pathogenic hallmarks of Alzheimer's disease (AD). In recent years, impairment of autophagy has been identified as another [...]
Categories: I-RECOVER Post-Vaccine
Authors: Nunez-Castilla J, Stebliankin V, Baral P, Balbin CA, Sobhan M, Cickovski T et al. PMID: 35891400 PMCID: PMC9318917 DOI: 10.3390/v14071415 Abstract Molecular mimicry between viral antigens and host proteins can produce cross-reacting antibodies leading to autoimmunity. The coronavirus SARS-CoV-2 causes COVID-19, a disease curiously resulting in varied symptoms and outcomes, ranging from asymptomatic to [...]
Categories: I-RECOVER Post-Vaccine
Tags: Autoimmunity, SARS-CoV-2
Authors: Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Lu S et al. doi: https://doi.org/10.1101/2022.06.21.22276660 Abstract Epstein-Barr virus (EBV) reactivation has been proposed as a driver of Long COVID (LC), but studies in well- characterized post-acute COVID-19 cohorts of individuals with and without Long COVID symptoms over a time course consistent with current [...]
Categories: I-RECOVER Post-Vaccine
Tags: Epstein-Barr Virus, long COVID
Authors: Gallardo-Zapata J, Maldonado-Bernal C PMID: 35733383 PMCID: PMC9389049 DOI: 10.1177/17534259221077750 Abstract At the end of 2019, an outbreak of a severe respiratory disease occurred in Wuhan China, and an increase in cases of unknown pneumonia was alerted. In January 2020, a new coronavirus named SARS-CoV-2 was identified as the cause. The virus spreads primarily [...]
Categories: I-RECOVER Post-Vaccine
Tags: SARS-CoV-2